Stocklytics Platform

Income Statement

publish
The Stocklytics Income Statement Screener empowers investors to focus on companies with strong financial fundamentals. Whether you’re interested in growth, profitability, or overall revenue strength, this tool helps you make informed decisions.
name
arrow_downwardRevenue Price $ Change % Change Revenue Growth % Gross Profit Operating Income Net Income EBITDA EPS Diluted
Asset logo for symbol WINT
WINTWindtree Therapeutics
_$0.47$0.00arrow_drop_up1.56%-_-$17.53M-$20.29M-$24.66M-19.03AI Analysis
ATMV
ATMVAlphaVest Acquisition
_$11.24-$0.01arrow_drop_down0.08%-_-$676.31K$2.90M$0.000.41AI Analysis
Asset logo for symbol NMRD
NMRDNemaura Medical
_$0.02-$0.00arrow_drop_down4.00%-_-$9.59M-$14.14M-$11.29M-0.39AI Analysis
Asset logo for symbol PMCB
PMCBPharmaCyte Biotech
_$1.85$0.10arrow_drop_up6.25%-_-$8.52M$333.76K$0.000.62AI Analysis
Asset logo for symbol VTVT
VTVTvTv Therapeutics
_$16.42-$0.48arrow_drop_down2.84%-_-$25.50M-$20.25M-$22.76M-6.63AI Analysis
WKSP
WKSPWWorksport Ltd.
_$0.02$0.00arrow_drop_up52.04%-$240.51K-$14.73M-$14.92M-$13.55M-0.54AI Analysis
ZIVO
ZIVOWZIVO Bioscience
_$0.35$0.13arrow_drop_up65.87%-$11.61K-$7.26M-$7.77M$0.000.00AI Analysis
NXG
NXGNXG NextGen Infrastructure Income Fund
_$47.45$0.42arrow_drop_up0.89%-_-$28.51M-$28.51M$0.003.12AI Analysis
Asset logo for symbol MEIP
MEIPMEI Pharma
_$2.85-$0.01arrow_drop_down0.34%arrow_drop_up33.76%$49.32M$14.54M$17.77M$36.72M2.67AI Analysis
Asset logo for symbol GLT
GLTPH Glatfelter Co
_$21.05-$1.55arrow_drop_down6.85%-$129.70M$2.71M-$78.10M$67.96M-20.28AI Analysis
Asset logo for symbol DOMA
DOMADoma Holdings
_$6.28$0.000.00%-_-$74.89M-$95.28M-$45.29M-5.74AI Analysis
Asset logo for symbol AKAN
AKANAkanda
_$1.42$0.02arrow_drop_up1.50%-$111.44K-$10.05M-$32.27M-$7.46M-524.76AI Analysis
Asset logo for symbol PCVX
PCVXVaxcyte
_$87.39$0.31arrow_drop_up0.35%-_-$468.04M-$402.26M-$599.02M-4.58AI Analysis
Asset logo for symbol ELYM
ELYMEliem Therapeutics
_$5.16$0.06arrow_drop_up1.17%-_-$21.46M-$35.11M$0.00-2.22AI Analysis
Asset logo for symbol NRXPW
NRXPWNRx Pharmaceuticals
_$0.07$0.01arrow_drop_up18.76%-_-$27.58M-$30.15M-$23.25M-6.24AI Analysis
CSLM
CSLMWConsilium Acquisition Corp I, Ltd.
_$0.08$0.080.00%-_-$1.62M$4.62M$0.000.00AI Analysis
Asset logo for symbol UWMC
UWMCUWM Holdings Corporation Class
_$6.19-$0.04arrow_drop_down0.72%arrow_drop_up19.62%$1.88B$1.09B-$13.23M$300.19M-0.23AI Analysis
Asset logo for symbol TCS
TCSContainer Store Group
_$4.29$0.16arrow_drop_up3.87%-$488.76M-$104.73M-$103.28M$39.98M-29.86AI Analysis
Asset logo for symbol AOUT
AOUTAmerican Outdoor Brands
_$9.20-$0.02arrow_drop_down0.21%arrow_drop_up5.17%$88.42M-$12.49M-$12.24M$3.60M-0.81AI Analysis
Asset logo for symbol IHRT
IHRTiHeartMedia
_$2.37$0.15arrow_drop_up6.75%-$2.25B-$797.31M-$1.10B$1.49B-6.81AI Analysis
Showing 3721-3740 of 4977
Results per page:

Gain deeper insights into a company's earnings with the Stocklytics Income Statement Screener, designed to rank stocks in descending order of revenue. This tool allows you to quickly assess companies with the highest revenue and their overall income performance, providing key financial metrics for smarter investment decisions. Our screener offers detailed insights into the following income statement components: - Revenue Growth – Identify companies with impressive year-over-year growth, a critical indicator of potential future success. - Gross Profit – Analyze how well a company is managing its core production costs to generate profit. - Operating Income – Understand a company’s ability to generate profit from its primary operations, excluding non-operational activities. - Net Income – Examine the company's bottom line after all expenses, providing a clear picture of profitability. - EBITDA – Evaluate a company’s earnings before interest, taxes, depreciation, and amortization to get a sense of its overall profitability and operating performance. - EPS Diluted – Review earnings per share on a diluted basis, reflecting potential impacts of convertible securities and giving you a clearer picture of shareholder returns. By using the Stocklytics Income Statement Screener, you’ll have access to vital financial data that will help you evaluate a company's performance, profitability, and growth potential. Why the Income Statement Matters: - Revenue Performance: Understand which companies are excelling at generating top-line revenue. - Profitability: Analyze margins and earnings to identify financially strong companies. - Earnings Per Share: Evaluate companies with high earnings per share, a key metric for investors.
toolkit image

Discover the Power of Stocklytics Tools

Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.

See Stocklytics Tools

Take Your Investments to a Whole New Level